Frontiers in Cardiovascular Medicine

JULY 16, 2024

This study aims to investigate the associations of NPAR level with all-cause and CVD-cause mortality among patients with hypertension.MethodsThis prospective cohort study included 8,990 patients with hypertension who participated in the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2010.

Hypertension 52

Hypertension Cardiovascular Disease Document Outcomes 52

Heart BMJ

DECEMBER 20, 2023

Rheumatic heart disease mortality in Indigenous and non-Indigenous Australians between 2010 and 2017. Stacey I, Seth R, Nedkoff L, et al. Heart 2023; 109 :1025-1033. This article has been corrected since it was first published. A typographical error in the title has been corrected; the years should have been between 2013 and 2017.

Heart Disease 40

Heart Disease Article 40

Open Heart

MARCH 25, 2025

We included adults with community-acquired BSI between 2010 and 2020. Methods This self-controlled case series study was conducted within the Secure Anonymised Information Linkage Databank, containing anonymised population-scale electronic health record data for Wales, UK.

Myocardial Infarction 52

Myocardial Infarction Strokes Stroke Cardiovascular Disease 52

Journal of the American Heart Association

MARCH 8, 2024

The aim of this study was to assess the frequency of race reporting and proportions of race and ethnicity representation in stroke‐related clinical trials.Methods and ResultsThis is a descriptive study of stroke‐related clinical trials completed between January 1, 2010 and December 31, 2020, and registered onClinicalTrials.gov.

Strokes 40

Strokes Stroke Outcomes 40

HeartRhythm

FEBRUARY 27, 2025

Crucial to the field were the initial diagnostic criteria proposed in 1994 and later revised in 2010. For the past several decades, research on arrhythmogenic right ventricular (RV) cardiomyopathy has focused on describing the clinical features, genetic underpinnings, and natural history of patients with this condition.

Cardiomyopathy 40

Cardiomyopathy Research 40

Stroke Journal

JANUARY 21, 2024

The objective of this analysis was to evaluate the stroke burden across European regions and countries in 2019 and its difference to 2010.METHODS:The The objective of this analysis was to evaluate the stroke burden across European regions and countries in 2019 and its difference to 2010.METHODS:The

Strokes 40

Strokes Stroke 40

Hypertension Journal

OCTOBER 11, 2023

BACKGROUND:Despite increasing incidences of hypertension, recent trends in mortality and urgent dialysis following acute hypertension (AHT) remain undetermined.METHODS:This retrospective observational cohort study evaluated 50 316 hospitalized AHT patients from 2010 to 2019, using an administrative claims database in Japan.

Hypertension 40

Hypertension Kidney Disease Heart Failure Risk Factors 40

CardiacWire

JANUARY 31, 2025

In 2010, the AHA released a 2020 goal to improve the CV health of all Americans by 20%, while reducing CVD and stroke deaths by 20%. Another year, another AHA report reasserting heart diseases dominance as the number one killer in the United States, and the latest data shows that this trend is still gaining momentum.

Cardiovascular Disease 59

Cardiovascular Disease Obesity Heart Disease Public Health 59

Stroke Journal

MARCH 21, 2024

We sought to determine how often acute stroke trials included PROMs as outcome measures and assessed the completeness of methodological reporting.METHODS:We searched MEDLINE for randomized controlled trials published in 9 high-impact journals between 2010 and 2020.

Strokes 40

Strokes Stroke Outcomes Quality of Life 40

Stroke Journal

JANUARY 30, 2025

We compared the FCA patients in VIPS II to those in VIPS I (2010-2014), the prospective cohort study with similar methods.Results:Of 75 children with definite arteriopathy enrolled in VIPS II, 43% had FCA, compared to 32% of 127 definite arteriopathy cases in VIPS I (Table). Study neuroradiologist (M.W.)

Pediatrics 40

Pediatrics Outcomes Strokes Stroke 40

Open Heart

JANUARY 31, 2024

Background There is a paucity of data on the initiation patterns of anticoagulants among older atrial fibrillation patients with and without chronic kidney disease (CKD).

Kidney Disease 40

Kidney Disease Atrial Fibrillation Research 40

American College of Cardiology

FEBRUARY 6, 2025

million Danish citizens in 2010. Patients with a history of cardiovascular disease, compared with those without, had a higher incidence of sudden cardiac death (SCD), according to a study of 5.5

Sudden Cardiac Death 64

Sudden Cardiac Death Cardiovascular Disease Article 64

DAIC

MARCH 28, 2025

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet. Eur J Radiol. 2008;66(1):3741. doi:10.1016/j.ejrad.2007.05.006. 2007.05.006. iii Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. 2012) 380:2095128.

Technology 52

Technology Coronary Artery Disease Atrial Fibrillation Medicare 52

Journal of the American Heart Association

FEBRUARY 29, 2024

Generalized linear models with Poisson distribution were used to examine the prevalence and prevalence ratios of self‐reported hypertension, diabetes, high cholesterol, physical inactivity, smoking, and overweight/obesity among Asian subgroups compared with US‐born NHW adults.

Risk Factors 40

Risk Factors Obesity Diabetes Cholesterol 40

CardiacWire

APRIL 21, 2024

in 2000-2010 to 30.9% The researchers analyzed 2000-2022 data from 3.5M Danish people who didn’t have AFib at baseline (45-95yrs, 48yr avg, 51.7% women), including 362k people who experienced AFib during the study period: Lifetime AFib risk was 27.7% overall, increasing from 24.2% in 2011-2022. lifetime risk, which remained stable at 42.9%

AFIB 105

AFIB Heart Failure Myocardial Infarction Strokes 105

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

years old] between 2010 and 2021. Almost 114,000 pacemakers were implanted between 2010 and 2021, of which 27.9% Conclusion This study followed all Czech patients with pacemaker’s implantation in between 2010 and 2021. were single-chamber, 67.4% were dual-chamber and 4.6% were biventricular.

Pacemaker 64

Pacemaker Reimbursement COVID-19 64

Circulation: Cardiovascular Interventions

NOVEMBER 9, 2023

Circulation: Cardiovascular Interventions, Ahead of Print.

Aortic valve 40

Aortic valve Aortic Cardiovascular Interventions Stenosis 40

Circulation

DECEMBER 4, 2023

The American Heart Association sponsored the first iteration of a scientific statement that addressed all aspects of cardiovascular implantable electronic device infection in 2010. Major advances in the prevention, diagnosis, and management of these infections have occurred since then, necessitating a scientific statement update.

Circulation 75

Circulation Outcomes 75

DAIC

MARCH 27, 2024

Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Glob Heart. 2014;9(1):145-158 e121. 2013;382(9901):1329-1340.

Peripheral Arterial Disease 111

Peripheral Arterial Disease Ischemia Technology Coronary Artery Disease 111

DAIC

JUNE 24, 2024

She then became a Hospital Board Senior Director in 2010. At the same time, the example set by Ann redefined the landscape for transformational philanthropy across this city, and for children’s hospitals across the country. Ann served as a member on the Hospital, Research Institute, and Foundation Boards in the 1990s and 2000s.

Hospital 105

Hospital Critical Care Nursing Pediatrics 105

HCPLive

DECEMBER 24, 2023

Cross-sectional data show an increasing incidence of syphilitic uveitis–related hospitalizations in the US between 2010 and 2019.

Hospital 52

Hospital 52

Heart BMJ

JULY 10, 2024

1 From 2010 to 2020, there was a global increase of ~19% in CV deaths. Introduction Cardiovascular disease (CVD) is the leading cause of mortality worldwide, resulting in ~18 million deaths annually. 1 Atherosclerotic CVD (ASCVD) accounts for four out of every five cardiovascular (CV) deaths, one-third of which are premature.

Cardiovascular Disease 64

Cardiovascular Disease Risk Factors 64

Hypertension Journal

FEBRUARY 23, 2024

Participants were grouped according to the date of their National Health and Nutrition Examination Survey study visit (1988–1994, 1999–2004, 2005–2010, 2011–2016).Results:There 0.95) for the 2005 to 2010 cohort, and 0.89 (95% CI, 0.75–1.05) 0.74) for the 2005 to 2010 cohort, and 0.57 (95% CI, 0.44–0.74)

Hypertension 45

Hypertension Certification Blood Pressure Cardiovascular Disease 45

Journal of the American Heart Association

FEBRUARY 27, 2025

We assessed diversityBP, diversityBP, and microbe abundancesBP associations using linear regression, permutational multivariate analysis of variance, and betabinomial count regression, respectively.

Blood Pressure 75

Blood Pressure 75

Dr. Malcolm Kendrick

JANUARY 29, 2025

Here are the stated aims 2 : In meeting its aims, the Inquiry will: a) consider any disparities evident in the impact of the pandemic on different categories of people, including, but not limited to, those relating to protected characteristics under the Equality Act 2010 and equality categories under the Northern Ireland Act 1998.

COVID-19 105

COVID-19 Outcomes 105

Open Heart

AUGUST 22, 2022

years) between January 2010 and December 2019. After 1:2 PS matching (trastuzumab users, TZ, n=1005; non-users, NT, n=2010), Cox proportional hazards model analysis showed that the rate of heart failure development within 18 months postoperative was significantly higher in the TZ group than in the NT group (adjusted HR 2.28, 95% CI 1.38

Cardio Oncology 52

Cardio Oncology Cancer Heart Failure Risk Factors 52

Open Heart

MAY 2, 2023

Patients were randomised to either first-line cardiovascular magnetic resonance (CMR), single-photon emission computed tomography (SPECT) or the UK National Institute for Health and Care Excellence (NICE) CG95 (2010) guidelines-directed care. 12) Questionnaire and EuroQol-5 Dimension Questionnaire were recorded.

Chest Pain 52

Chest Pain Quality of Life Angina Coronary Artery Disease 52

HeartRhythm

AUGUST 18, 2024

Diagnosis of ARVC is based on the 2010 Task Force Criteria (TFC), application of which often requires clinical expertise at specialized centers. Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetic heart disease associated with life-threatening ventricular arrhythmias.

Cardiomyopathy 40

Cardiomyopathy Arrhythmia Heart Disease 40

HeartRhythm

APRIL 30, 2024

Diagnosis of ARVC using the 2010 Task Force Criteria is the first step in identifying patients at risk for life-threatening arrhythmias caused by this rare genetic disease. However, appropriate application of ECG criteria often requires clinical expertise at specialized centers.

Cardiomyopathy 40

Cardiomyopathy Arrhythmia 40

Journal of the American Heart Association

FEBRUARY 16, 2024

The primary objective of the present study was to determine whether CPR based on CoSTR 2005 or 2010 was associated with improved outcomes in Japan, as compared with CPR based on Guidelines 2000.Methods in 2006, and 3.01

Cardiac Arrest 40

Cardiac Arrest Hospital Outcomes 40

Circulation: Cardiovascular Interventions

JANUARY 24, 2025

However, IVI is underutilized and is not yet established as a performance measure for quality PCI.METHODS:We examined temporal trends of IVI use for all PCIs performed at Veterans Affairs hospitals in the United States from 2010 to 2022 using retrospective observational cohorts. in 2010 to 43.1%

Hospital 45

Hospital Ultrasound Cardiovascular Interventions Outcomes 45

Open Heart

MAY 9, 2022

Methods and results We prospectively collected data on 4 099 281 echocardiographic studies entered directly into a central electronic database from 63 laboratories across four Australian states between 2010 and 2021. Between 2010 and 2014 there were significant improvements in data completeness (72.0%+/-26.8%

Laboratory 52

Laboratory Technology Outcomes 52

Cardiology Update

JUNE 24, 2024

Integration and Advancements In the second stage, spanning the 1980s to 2010, significant progress was made in using magnetic resonance technology to capture various cardiovascular images. The third stage, beginning in 2010 and continuing today, emphasized the widespread clinical use of CMR.

Myocardial Infarction 52

Myocardial Infarction Anatomy Cardiovascular Imaging Research 52

Frontiers in Cardiovascular Medicine

JANUARY 31, 2024

The mean Pediatric Vasculitis Activity Score (PVAS), Takayasu Clinical Activity Score (ITAS-2010) and ITAS-A scores were 2.8/63, The most common initial manifestations were malaise (80%), fever (70%), hypertension (50%) and rash (30%). 51, and 5.6/54, 54, respectively. All patients had aberrant laboratory parameters.

Laboratory 64

Laboratory Pediatrics Hypertension Outcomes 64

Circulation: Cardiovascular Imaging

DECEMBER 18, 2023

We aimed to evaluate the diagnostic and prognostic utility of LV and RV strain in ARVC.METHODS:Patients with suspected ARVC (n = 109) from a multicenter registry were clinically phenotyped using the 2010 ARVC Revised Task Force Criteria and underwent baseline strain echocardiography. years, and 48% of patients were female.

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Cardiovascular Imaging Transplant 40

Conquering CHD

FEBRUARY 1, 2024

History of the Congenital Heart Futures Act First passed into law in 2010, the bipartisan Congenital Heart Futures Act was groundbreaking legislation authorizing research and data collection specific to Congenital Heart Disease.

Congenital 98

Congenital Congenital Heart Disease Public Health Pediatrics 98

HeartRhythm

APRIL 30, 2024

Diagnosis and assessment of disease progression in arrhythmogenic cardiomyopathy (ACM) are currently based on the 2010 Task Force Criteria (TFC) with the 12-lead electrocardiogram (ECG) being an important modality. The presence of inverted T-waves might be associated with lethal ventricular arrhythmias.

Cardiomyopathy 40

Cardiomyopathy Electrocardiogram Arrhythmia 40